561 related articles for article (PubMed ID: 9003198)
1. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2.
Fei YJ; Liu W; Prasad PD; Kekuda R; Oblak TG; Ganapathy V; Leibach FH
Biochemistry; 1997 Jan; 36(2):452-60. PubMed ID: 9003198
[TBL] [Abstract][Full Text] [Related]
2. Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1.
Chen XZ; Steel A; Hediger MA
Biochem Biophys Res Commun; 2000 Jun; 272(3):726-30. PubMed ID: 10860823
[TBL] [Abstract][Full Text] [Related]
3. The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.
Geissler S; Zwarg M; Knütter I; Markwardt F; Brandsch M
FEBS J; 2010 Feb; 277(3):790-5. PubMed ID: 20067523
[TBL] [Abstract][Full Text] [Related]
4. Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.
Covitz KM; Amidon GL; Sadée W
Biochemistry; 1998 Oct; 37(43):15214-21. PubMed ID: 9790685
[TBL] [Abstract][Full Text] [Related]
5. Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras.
Fei YJ; Liu JC; Fujita T; Liang R; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(1):39-44. PubMed ID: 9600064
[TBL] [Abstract][Full Text] [Related]
6. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
[TBL] [Abstract][Full Text] [Related]
7. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Kaku T; Liu K
Peptides; 2012 Apr; 34(2):395-403. PubMed ID: 22369721
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of tryptophan residues to conserved hydrophobic residues inhibits the processing of human KB cell folate receptor.
Chung KN; Paik TH; Roberts S; Kim CH; Kirassova M; Weinstein JN; Trepel JB; Elwood PC
Arch Biochem Biophys; 1994 Dec; 315(2):407-14. PubMed ID: 7986085
[TBL] [Abstract][Full Text] [Related]
9. His257 is a uniquely important histidine residue for tetracycline/H+ antiport function but not mandatory for full activity of the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
Yamaguchi A; Samejima T; Kimura T; Sawai T
Biochemistry; 1996 Apr; 35(14):4359-64. PubMed ID: 8605184
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2.
Sala-Rabanal M; Loo DD; Hirayama BA; Wright EM
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1422-32. PubMed ID: 18367661
[TBL] [Abstract][Full Text] [Related]
11. Structure-function studies of the brain-type glucose transporter, GLUT3: alanine-scanning mutagenesis of putative transmembrane helix VIII and an investigation of the role of proline residues in transport catalysis.
Seatter MJ; Kane S; Porter LM; Arbuckle MI; Melvin DR; Gould GW
Biochemistry; 1997 May; 36(21):6401-7. PubMed ID: 9174356
[TBL] [Abstract][Full Text] [Related]
12. Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function.
Döring F; Martini C; Walter J; Daniel H
J Membr Biol; 2002 Mar; 186(2):55-62. PubMed ID: 11944083
[TBL] [Abstract][Full Text] [Related]
13. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
del Camino D; Barros F; Pardo LA; de la Peña P
Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis of residues in a conserved region of bovine aspartyl (asparaginyl) beta-hydroxylase: evidence that histidine 675 has a role in binding Fe2+.
McGinnis K; Ku GM; VanDusen WJ; Fu J; Garsky V; Stern AM; Friedman PA
Biochemistry; 1996 Apr; 35(13):3957-62. PubMed ID: 8672427
[TBL] [Abstract][Full Text] [Related]
15. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
16. Functional importance of GGXG sequence motifs in putative reentrant loops of 2HCT and ESS transport proteins.
Dobrowolski A; Lolkema JS
Biochemistry; 2009 Aug; 48(31):7448-56. PubMed ID: 19594131
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H+/peptide cotransporter, PEPT1.
Saito H; Motohashi H; Mukai M; Inui K
Biochem Biophys Res Commun; 1997 Aug; 237(3):577-82. PubMed ID: 9299407
[TBL] [Abstract][Full Text] [Related]
18. Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.
Uchiyama T; Kulkarni AA; Davies DL; Lee VH
Pharm Res; 2003 Dec; 20(12):1911-6. PubMed ID: 14725353
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis studies on a putative fifth iron ligand of mouse 8S-lipoxygenase: retention of catalytic activity on mutation of serine-558 to asparagine, histidine, or alanine.
Jisaka M; Boeglin WE; Kim RB; Brash AR
Arch Biochem Biophys; 2001 Feb; 386(2):136-42. PubMed ID: 11368335
[TBL] [Abstract][Full Text] [Related]
20. Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3.
Katai K; Miyamoto K; Kishida S; Segawa H; Nii T; Tanaka H; Tani Y; Arai H; Tatsumi S; Morita K; Taketani Y; Takeda E
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):705-12. PubMed ID: 10527952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
